The launch of BrightMeds GLP-1 marks a crucial shift in how physicians approach type 2 diabetes . This advanced medication type offers a unique mechanism of action that also lowers sugar but also promote weight loss and enhance cardiovascular health . Early findings suggest this therapy be a a powerful resource for patients needing better continued